Google is making another move into the profitable sphere of diabetes management: Its Life Sciences arm—which will soon fall under Google's new parent company, Alphabet—is announcing a partnership with Sanofi, a French pharmaceutical company, to build new treatment products for diabetes. The two firms will collaborate on product development and new methods for monitoring the condition.